Case Report: Minimally invasive surgical management of a complex high rectovaginal fistula caused by long-term retained and migrated intrauterine device - Report - MDSpire
Advertisement
Case Report: Minimally invasive surgical management of a complex high rectovaginal fistula caused by long-term retained and migrated intrauterine device
Clinical Report: Innovative Minimally Invasive Approach for Managing a Complex High Rectovaginal Fistula
Background
Rectovaginal fistula is a rare but distressing condition that can arise from various causes, including migrated IUDs. High-level RVFs pose significant surgical challenges due to their complex anatomy and high recurrence rates. This case highlights the importance of multidisciplinary approaches in managing such intricate clinical scenarios.
Data Highlights
No numerical data available.
Key Findings
A 43-year-old female presented with a 1-cm fistula and a migrated IUD embedded in the rectal wall.
Prior attempts to remove the IUD were unsuccessful due to technical limitations and complex tissue anatomy.
The patient underwent a combined laparoscopic proctectomy and transabdominal-transvaginal fistula repair.
No postoperative complications occurred, and the ileostomy was successfully closed at 3 months.
During the 6-month follow-up, there were no signs of fistula recurrence or fecal incontinence.
Clinical Implications
This case demonstrates the effectiveness of a combined laparoscopic approach for managing high-level RVFs associated with migrated IUDs. It underscores the need for careful preoperative evaluation and multidisciplinary collaboration in complex pelvic surgeries.
Conclusion
The combined laparoscopic transabdominal-transvaginal approach is a viable surgical option for high-level RVFs, offering safety and effectiveness in managing this rare complication.
Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.